Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QLD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,755
Award facts
- Contract value 100% obligated
- $12,755.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,755.10 for Dupixent 300 mg/2 mL pens on December 3, 2025, with completion scheduled for December 4, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, representing a specialty pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a $999.999 billion ceiling value through December 2026. The parent IDC functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. The company's track record of consistent competitively-awarded contracts demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains and transaction sizes.
Quick answers
Who was awarded contract SPE2DR26F3QLD?
SPE2DR26F3QLD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F3QLD worth?
The government has obligated $12,755 on SPE2DR26F3QLD.
Is contract SPE2DR26F3QLD an order under another contract?
Yes. SPE2DR26F3QLD is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QLD competed?
The extent of competition for SPE2DR26F3QLD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award